HPV16 E5 Mediates Resistance to PD-L1 Blockade and can be targeted with Rimantadine in Head and Neck Cancer

There is a critical need to understand mechanisms of resistance and develop combinatorial strategies to improve responses to checkpoint blockade immunotherapy (CBI). Here we uncover a novel mechanism by which the human papillomavirus (HPV) inhibits the activity of CBI in head and neck squamous cell...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Miyauchi, Sayuri, Sanders, P. Dominick, Guram, Kripa, Kim, Sangwoo S., Paolini, Francesca, Venuti, Aldo, Cohen, Ezra E. W., Gutkind, J. Silvio, Califano, Joseph A., Sharabi, Andrew B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7024675/
https://ncbi.nlm.nih.gov/pubmed/31848196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-19-1771
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados